Josep Castellví
- Molecular Biology top 5%
- Oncology top 2%
- Cancer Research top 2%
- Pulmonary and Respiratory Medicine top 5%
- Immunology top 5%
- Co-authors
- Santiago Ramón y CajalMatilde E. LleonartJavier Hernández‐LosaAntonio Gil‐MorenoCleofé RomagosaJosé BaselgaFederico RojoA. Mazo
- Topics
- Endometrial and Cervical Cancer Treatments (13 papers)Ovarian cancer diagnosis and treatment (11 papers)Lymphoma Diagnosis and Treatment (11 papers)
- Cited by
- Cancer ResearchVirologyOncology
- Partner nations
- SpainPalestinian TerritoryUnited States
In The Last Decade
Josep Castellví
107 papers receiving 3.6k citations
Hit Papers
Peers
Comparison fields: 5 of 122
- Molecular Biology 1.7k
- Oncology 1.0k
- Cancer Research 838
- Pulmonary and Respiratory Medicine 548
- Immunology 456
Countries citing papers authored by Josep Castellví
This map shows the geographic impact of Josep Castellví's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Josep Castellví with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Josep Castellví more than expected).
Fields of papers citing papers by Josep Castellví
This network shows the impact of papers produced by Josep Castellví. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Josep Castellví. The network helps show where Josep Castellví may publish in the future.
Co-authorship network of co-authors of Josep Castellví
This figure shows the co-authorship network connecting the top 25 collaborators of Josep Castellví. A scholar is included among the top collaborators of Josep Castellví based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Josep Castellví. Josep Castellví is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 1 | |
| 3 | 3 | |
| 4 | 14 | |
| 5 | Clinical implications of intratumor heterogeneity: challenges and opportunitiesbreakdown → | 313 |
| 6 | 74 | |
| 7 | 34 | |
| 8 | 34 | |
| 9 | 2 | |
| 10 | 75 | |
| 11 | 36 | |
| 12 | 42 | |
| 13 | 3 | |
| 14 | 24 | |
| 15 | 66 | |
| 16 | 38 | |
| 17 | 13 | |
| 18 | 47 | |
| 19 | 53 | |
| 20 | 11 |
About Josep Castellví
Josep Castellví is a scholar working on Obstetrics and Gynecology, Reproductive Medicine and Virology, having authored 109 papers that have together received 3.6k indexed citations. Recurring topics across this work include Endometrial and Cervical Cancer Treatments (13 papers), Ovarian cancer diagnosis and treatment (11 papers) and Lymphoma Diagnosis and Treatment (11 papers). The work is most often cited by research in Cancer Research (838 citations), Virology (188 citations) and Oncology (1.0k citations). Josep Castellví has collaborated with scholars based in Spain, Palestinian Territory and United States. Frequent co-authors include Santiago Ramón y Cajal, Matilde E. Lleonart, Javier Hernández‐Losa, Antonio Gil‐Moreno, Cleofé Romagosa, José Baselga, Federico Rojo, A. Mazo, Laura López-Vicente and S. Simonetti. Their work appears in journals such as Nature Communications, Journal of Clinical Oncology and The EMBO Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.